Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity
- PMID: 1281622
- PMCID: PMC1886764
Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity
Abstract
Immunohistochemical detection of cell cycle-related markers for estimation of tumor growth fractions using paraffin-embedded tissue sections would have applications in experimental and clinical pathology as an in situ histologic alternative to flow cytometry. The monoclonal antibodies 19A2 and PC10 detect the proliferating cell nuclear antigen (PCNA/Cyclin), an auxiliary protein to DNA polymerase-delta. In a prospective group of uniformly handled, formalin-fixed malignant lymphomas we previously demonstrated 19A2 to be a reliable marker of proliferative activity similar to Ki-67 in frozen tissue. The present study examines the applicability of this technique in archival formalin-fixed material. Studies on tonsilar tissue revealed that formalin fixation beyond 30 hours adversely affected reactivity of 19A2, possibly explaining the variable results in nonuniformly fixed archival material. We found that only 27 (56%) of 48 archival cases of infiltrating ductal carcinoma showed sufficient reactivity with 19A2 to permit reliable quantification of the tumor growth fraction. Acid pretreatment with 2N HCl had no apparent effect on 19A2 reactivity. Using both antibodies on a group of 32 archival lymphomas, carcinomas, and sarcomas, significantly more biopsies stained reliably for PC10 (84%) than for 19A2 (72%; P < 0.036). Further, none of the cases that did not react with PC10 reacted with 19A2. PC10 may recognize a different epitope of PCNA/Cyclin which may be more resistant to alterations by fixation. In the 23 cases that reliably stained for both markers, largely carcinomas, there was excellent correlation between estimated growth fractions (r = 0.96). Although immunostaining provides a useful way to estimate tumor growth fractions in paraffin-embedded tissues, modifications of technique and cautious interpretation of results are advisable when using archival material.
Similar articles
-
Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.Am J Pathol. 1991 Jun;138(6):1471-7. Am J Pathol. 1991. PMID: 1675840 Free PMC article.
-
Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.Biotech Histochem. 1994 Jul;69(4):203-12. doi: 10.3109/10520299409106288. Biotech Histochem. 1994. PMID: 7918835
-
Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.Am J Pathol. 1993 Apr;142(4):1081-9. Am J Pathol. 1993. PMID: 7682759 Free PMC article.
-
Detection of cell proliferation in tissue sections.Braz J Med Biol Res. 1993 Jul;26(7):677-87. Braz J Med Biol Res. 1993. PMID: 7903573 Review.
-
Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications.Histochem J. 1993 Dec;25(12):843-53. Histochem J. 1993. PMID: 7906685 Review.
Cited by
-
Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.Virchows Arch. 1995;427(3):295-301. doi: 10.1007/BF00203398. Virchows Arch. 1995. PMID: 7496600
-
Impact of simultaneous assay, the PCNA, cyclinD1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system.World J Gastroenterol. 2005 Jul 7;11(25):3823-9. doi: 10.3748/wjg.v11.i25.3823. World J Gastroenterol. 2005. PMID: 15991276 Free PMC article.
-
Apoptosis in human hepatocellular carcinoma and in liver cell dysplasia is correlated with p53 protein immunoreactivity.J Clin Pathol. 1997 May;50(5):394-400. doi: 10.1136/jcp.50.5.394. J Clin Pathol. 1997. PMID: 9215122 Free PMC article.
-
Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.Acta Neurochir (Wien). 1996;138(12):1456-63. doi: 10.1007/BF01411126. Acta Neurochir (Wien). 1996. PMID: 9030354
-
Chromatin-bound PCNA as S-phase marker in mononuclear blood cells of patients with acute lymphoblastic leukaemia or multiple myeloma.Cell Prolif. 2010 Dec;43(6):579-83. doi: 10.1111/j.1365-2184.2010.00707.x. Cell Prolif. 2010. PMID: 21039996 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous